To identify additional potential vulnerabilities, we analyzed the Pan-Cancer Atlas DNA methylation dataset for metabolic genes that met three criteria: (1) DNA methylation correlated strongly with gene expression, (2) methylation is variable across tumor types, and (3) the median gene methylation was at least as high as PSAT1 methylation in luminal tumors. The gene discussed is PSAT1; the disease is neoplasm.